Global E-Clinical solutions Market: Market Segments: By Product Type (CTMS, eCOA, Analytics, RTMS, eTMF, Safety, CDMS, EDC); By Delivery Mode (On-Demand, On-premise, Cloud-based; ByEnd-User (CROs, Hospitals, Pharma/Biopharma Companies); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
Product Overview
E-Clinical solutions combine clinical technology and experience and are used through data processing and data analysis to facilitate the clinical development process. In addition to the increasing number of CROs and life sciences organizations, the growing trend of outsourcing clinical trials to contract research organizations (CROs) is poised to help the industry gain considerable momentum in the coming years. Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Market Highlights
Global E-Clinical Solutions Market to surpass USD XXXX million by 2030 from USD XXXX million in 2018 at a CAGR of XX% throughout the forecast period, i.e. 2019-30.
Major factors characterizing the market growth are increasing R&D activities by biopharmaceutical and pharmaceutical companies, growing expenditure on the production of clinical trials, the burden of chronic diseases, and increased adoption of smart devices for healthcare management.
Global E-Clinical Solutions Market: Segments
Web-based delivery mode segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by delivery mode into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based solutions. The largest share in 2019 was in the Web-hosted (on-demand) segment. Multiple factors are responsible for their large market shares, such as easy user access, cost reductions, and faster data retrieval. During the forecast period, the cloud-based distribution mode segment is expected to report the highest growth rate. With a fixed monthly fee provided by cloud-based models, the ease of integration, faster implementation, and flexible scalability are expected to drive the market for these solutions.
The pharmaceutical and biopharmaceutical segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by end-users into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical. device manufacturers, hospitals, and academic research institutions. The multiple usages of E-Clinical solutions enhance the performance of clinical trials and decrease the total expense and time involved in the production of drugs. These advantages have resulted in a rise in pharmaceutical and biopharmaceutical companies' adoption of automated technology for medicines.
Global E-Clinical Solutions Market: Market Dynamics
Drivers
Increase in clinical trials
Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Stringent regulatory structure
In developed economies such as the United States, the existence of a strict regulatory framework for clinical trials and an increased need for safety monitoring also plays a vital role in the adoption of E-Clinical solutions in addition to this, during the review period, rising government grants for substantiated trials and growing the end-user base for E-Clinical solutions are likely to fuel the market.
Restraints
High operational costs associated with cleanrooms
High implementation costs coupled with the lack of trained professionals can pose a major obstacle to the growth of the market for E-Clinical solutions. It is also assumed that the materials used for the development of these technologies would have unique characteristics. The high cost-related installation and usage of cleanrooms are, however, expected to impede market growth during the forecast period.
Global E-Clinical Solutions Market: Regions
Global E-Clinical Solutions Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
Global E-Clinical Solutions Market in North America held the largest market share of XX.X% in the year 2019. The growing target population, coupled with the prevalence of lifestyle-related diseases such as diabetes and heart disease, is poised to stimulate the growth of E-Clinical solutions in the regional market. Also, the position of major players and the availability of advanced infrastructure is expected to accentuate the growth of the regional market.
Global E-Clinical Solutions Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global E-Clinical Solutions Market: Key Players
Oracle Corporation
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Medidata Solutions, In
Parexel International Corporation
Bioclinica, Inc. (A Subsidiary of Cinven)
Datatrak International, Inc.
CRF Health
ERT Clinical
Merge Healthcare Incorporated
Omnicomm Systems, Inc.
Maxisit Inc.
Bio-Optronics, Inc.
E-Clinical Solutions, LLC.
Global E-Clinical Solutions Market report also contains analysis on:
Global E-Clinical Solutions Market Segments:
By Product Type
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Clinical Analytics Platform
Randomization and Trial Supply Management (RTMS)
Clinical Data Integration Platform
Electronic Clinical Outcome Assessment (eCOA)
Safety Solutions
Electronic Trail Master Files (eTMF)
Regulatory Information Management Solutions (RIMS)
Others
By Delivery Mode
Cloud-based
Licensed Enterprise
Web-hosted
By End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Consulting Service Companies
Medical Device Manufacturers
Hospitals
Academic Research Institutions
E-Clinical Solutions Market Dynamics
E-Clinical Solutions Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
E-Clinical solutions combine clinical technology and experience and are used through data processing and data analysis to facilitate the clinical development process. In addition to the increasing number of CROs and life sciences organizations, the growing trend of outsourcing clinical trials to contract research organizations (CROs) is poised to help the industry gain considerable momentum in the coming years. Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Market Highlights
Global E-Clinical Solutions Market to surpass USD XXXX million by 2030 from USD XXXX million in 2018 at a CAGR of XX% throughout the forecast period, i.e. 2019-30.
Major factors characterizing the market growth are increasing R&D activities by biopharmaceutical and pharmaceutical companies, growing expenditure on the production of clinical trials, the burden of chronic diseases, and increased adoption of smart devices for healthcare management.
Global E-Clinical Solutions Market: Segments
Web-based delivery mode segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by delivery mode into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based solutions. The largest share in 2019 was in the Web-hosted (on-demand) segment. Multiple factors are responsible for their large market shares, such as easy user access, cost reductions, and faster data retrieval. During the forecast period, the cloud-based distribution mode segment is expected to report the highest growth rate. With a fixed monthly fee provided by cloud-based models, the ease of integration, faster implementation, and flexible scalability are expected to drive the market for these solutions.
The pharmaceutical and biopharmaceutical segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by end-users into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical. device manufacturers, hospitals, and academic research institutions. The multiple usages of E-Clinical solutions enhance the performance of clinical trials and decrease the total expense and time involved in the production of drugs. These advantages have resulted in a rise in pharmaceutical and biopharmaceutical companies' adoption of automated technology for medicines.
Global E-Clinical Solutions Market: Market Dynamics
Drivers
Increase in clinical trials
Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Stringent regulatory structure
In developed economies such as the United States, the existence of a strict regulatory framework for clinical trials and an increased need for safety monitoring also plays a vital role in the adoption of E-Clinical solutions in addition to this, during the review period, rising government grants for substantiated trials and growing the end-user base for E-Clinical solutions are likely to fuel the market.
Restraints
High operational costs associated with cleanrooms
High implementation costs coupled with the lack of trained professionals can pose a major obstacle to the growth of the market for E-Clinical solutions. It is also assumed that the materials used for the development of these technologies would have unique characteristics. The high cost-related installation and usage of cleanrooms are, however, expected to impede market growth during the forecast period.
Global E-Clinical Solutions Market: Regions
Global E-Clinical Solutions Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
Global E-Clinical Solutions Market in North America held the largest market share of XX.X% in the year 2019. The growing target population, coupled with the prevalence of lifestyle-related diseases such as diabetes and heart disease, is poised to stimulate the growth of E-Clinical solutions in the regional market. Also, the position of major players and the availability of advanced infrastructure is expected to accentuate the growth of the regional market.
Global E-Clinical Solutions Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global E-Clinical Solutions Market: Key Players
Oracle Corporation
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Medidata Solutions, In
Parexel International Corporation
Bioclinica, Inc. (A Subsidiary of Cinven)
Datatrak International, Inc.
CRF Health
ERT Clinical
Merge Healthcare Incorporated
Omnicomm Systems, Inc.
Maxisit Inc.
Bio-Optronics, Inc.
E-Clinical Solutions, LLC.
Global E-Clinical Solutions Market report also contains analysis on:
Global E-Clinical Solutions Market Segments:
By Product Type
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Clinical Analytics Platform
Randomization and Trial Supply Management (RTMS)
Clinical Data Integration Platform
Electronic Clinical Outcome Assessment (eCOA)
Safety Solutions
Electronic Trail Master Files (eTMF)
Regulatory Information Management Solutions (RIMS)
Others
By Delivery Mode
Cloud-based
Licensed Enterprise
Web-hosted
By End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Consulting Service Companies
Medical Device Manufacturers
Hospitals
Academic Research Institutions
E-Clinical Solutions Market Dynamics
E-Clinical Solutions Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
1. EXECUTIVE SUMMARY
2. GLOBAL E-CLINICAL SOLUTIONS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL E-CLINICAL SOLUTIONS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL E-CLINICAL SOLUTIONS MARKET
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. GLOBAL E-CLINICAL SOLUTIONS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada)
12.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
12.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
12.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
12.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
12.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product Type: Market Share (2020-2030F)
12.2.1. EDC & CDMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. CTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Clinical Analytics Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. RTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Clinical Data Integration Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. eCOA, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.7. Safety Solutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.8. eTMF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.9. RIMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.10. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By Delivery Mode: Market Share (2020-2030F)
12.3.1. Web-hosted, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Licensed Enterprise, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Softwall cleanrooms, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Cloud-based, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By End-Users: Market Share (2020-2030F)
12.4.1. Pharmaceutical and Biopharmaceutical Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 202-2030F
12.4.2. Contract Research Organizations, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Consulting Service Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Medical Device Manufacturers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.5. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. 12.4.4. ACADEMIC RESEARCH INSTITUTIONS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
14. COMPANY PROFILE
14.1. Oracle Corporation
14.1.1. Company Overview
14.1.2. Company Total Revenue (Financials)
14.1.3. Market Potential
14.1.4. Global Presence
14.1.5. Key Performance Indicators
14.1.6. SWOT Analysis
14.1.7. Product Launch
14.2. Medidata Solutions, Inc.
14.3. Parexel International Corporation
14.4. Bioclinica, Inc.
14.5. Datatrak International, Inc.
14.6. CRF Health
14.7. ERT Clinical
14.8. Merge Healthcare Incorporated
14.9. Omnicomm Systems, Inc.
14.10. Other Prominent Players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL E-CLINICAL SOLUTIONS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL E-CLINICAL SOLUTIONS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL E-CLINICAL SOLUTIONS MARKET
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. GLOBAL E-CLINICAL SOLUTIONS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada)
12.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
12.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
12.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
12.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
12.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product Type: Market Share (2020-2030F)
12.2.1. EDC & CDMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. CTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Clinical Analytics Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. RTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Clinical Data Integration Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. eCOA, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.7. Safety Solutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.8. eTMF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.9. RIMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.10. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By Delivery Mode: Market Share (2020-2030F)
12.3.1. Web-hosted, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Licensed Enterprise, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Softwall cleanrooms, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Cloud-based, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By End-Users: Market Share (2020-2030F)
12.4.1. Pharmaceutical and Biopharmaceutical Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 202-2030F
12.4.2. Contract Research Organizations, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Consulting Service Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Medical Device Manufacturers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.5. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. 12.4.4. ACADEMIC RESEARCH INSTITUTIONS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
14. COMPANY PROFILE
14.1. Oracle Corporation
14.1.1. Company Overview
14.1.2. Company Total Revenue (Financials)
14.1.3. Market Potential
14.1.4. Global Presence
14.1.5. Key Performance Indicators
14.1.6. SWOT Analysis
14.1.7. Product Launch
14.2. Medidata Solutions, Inc.
14.3. Parexel International Corporation
14.4. Bioclinica, Inc.
14.5. Datatrak International, Inc.
14.6. CRF Health
14.7. ERT Clinical
14.8. Merge Healthcare Incorporated
14.9. Omnicomm Systems, Inc.
14.10. Other Prominent Players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
